← Every company
Abbott Laboratories SEC Filings
What Abbott Laboratories has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
ABT overview →Filings on file
147
since Oct 19, 2016
Warning signs
6
latest Dec 19, 2019
Last results
Jul 16, 2026
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
| Filed | What it reports | Document |
|---|---|---|
| Dec 19, 2019 | Debt acceleratedMaterial agreement 8-K | Read ↗ |
| Feb 25, 2019 | Debt acceleratedMaterial agreement 8-K | Read ↗ |
| Oct 29, 2018 | Debt acceleratedMaterial agreement 8-K | Read ↗ |
| Sep 28, 2018 | Debt acceleratedMaterial agreementNew debt 8-K | Read ↗ |
| Jun 22, 2018 | Debt accelerated 8-K | Read ↗ |
| Mar 22, 2018 | Debt acceleratedMaterial agreement 8-K | Read ↗ |
Source: Abbott Laboratories's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.
More on ABT
Company overviewEverything on ABT in one place, with the price.Insider tradingWhat ABT's own officers and directors buy and sell.Who owns itEvery manager reporting a position in ABT.Funds holding itWhich funds and ETFs hold ABT, and how big a bet.LobbyingWhat ABT spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on ABT's account, and who they worked for.Federal contractsWhat federal agencies pay ABT.PatentsWhat ABT is filing at the patent office.